You are here

Article Text

Article menu
Download PDFPDF
DTB Select
Gabapentin and risk of severe respiratory depression

https://doi.org/10.1136/dtb.2018.1.0571

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    In a recent Drug Safety Update, the Medicines and Healthcare products Regulatory Agency (MHRA) warned about a rare risk of severe respiratory depression with gabapentin, with or without concomitant use of opioids.1 In England, 6.5 million prescriptions for gabapentin were dispensed in 2016.2

    A European review of gabapentin was triggered by reports of patients developing respiratory depression without concomitant …

    View Full Text